Literature DB >> 5664318

Method for the estimation of acetylisoniazid in urine.

P Venkataraman, L Eidus, S P Tripathy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5664318     DOI: 10.1016/0041-3879(68)90023-8

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


× No keyword cloud information.
  10 in total

1.  Simplification of isoniazid phenotyping procedure to promote its application in the chemotherapy of tuberculosis.

Authors:  L Eidus; P Varughese; M M Hodgkin; A H Hsu; K B McRae
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

2.  Comparative blood levels and metabolism of INH and an INH-matrix preparation in fast and slow inactivators.

Authors:  C W Jeanes; O Schaefer; L Eidus
Journal:  Can Med Assoc J       Date:  1973-09-15       Impact factor: 8.262

3.  Screening of isoniazid inactivators.

Authors:  L Eidus; M M Hodgkin
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

4.  The determination of isoniazid and its metabolites acetylisoniazid, monoacetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine.

Authors:  G A Ellard; P T Gammon; S M Wallace
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.857

5.  Simplified isoniazid acetylator phenotyping.

Authors:  D W Russell; L Eidus
Journal:  Can Med Assoc J       Date:  1972-06-10       Impact factor: 8.262

6.  Inactivation of isoniazid by Canadian Eskimos and Indians.

Authors:  C W Jeanes; O Schaefer; L Eidus
Journal:  Can Med Assoc J       Date:  1972-02-19       Impact factor: 8.262

7.  Inactivation of isoniazid by condensation in a syrup preparation.

Authors:  K V Rao; S Kailasam; N K Menon; S Radhakrishna
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

8.  Simple method for determining isoniazid acetylator phenotype.

Authors:  D W Russell
Journal:  Br Med J       Date:  1970-08-08

9.  Isoniazid acetylation rates (phenotypes) of patients being treated for tuberculosis.

Authors:  E Mason; D W Russell
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

10.  Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens.

Authors:  G A Ellard; P T Gammon
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.